This Chair will focus on the evaluation of improved and safe TB preventive and treatment strategies in HIV-infected and uninfected children. Evaluation of novel drug regimens for MDR-TB prevention and treatment will be a key priority. Other research focus areas include improved TB diagnosis in children, including novel diagnostics and biomarkers, evaluation of novel TB vaccine strategies and implementation of science research to improve the care, recording and reporting of TB in children.
-ethics/149018470019475.png)
 | Prof Anneke Hesseling |
